We’ve been working with a group of world-class partners Toronto Rehabilitation Institute & Apollo Applied Research Inc to develop an advanced cognitive screen to assist in the detection of cannabis impairment. Neil Vorano spoke with CEO Tracy Milner to discuss the project and its implications for the future of roadside detection.
Read the full story here: One of the most advanced tests for cannabis impairment is being developed in Toronto.
Get in touch with us below to learn more
Let's make the INVISIBLE effects of brain disorders VISIBLE, together.
Copyright © 2022 - BrainFx. All rights reserved.
Important Information: BrainFx Assessments only provide information about neurofunctional performance. Assessment results detail the patient/client's performance on assessment activities completed and only assist the health care team in identifying potential areas of strength or challenge as related to function. Assessments DO NOT provide any diagnosis or treatment recommendations. BrainFx Assessments are only permitted to be delivered by trained clinicians. Assessment reports are not stand-alone and require the interpretation of a health professional within their scope of practice and in the context of all information that they have gathered about their patient/client. In Canada, BrainFx Assessments are cleared by Health Canada as a Class 1 Software as a Medical Device. BrainFx Assessments and the statements made on this website have not been evaluated by any other regulatory bodies. Assessments are not intended to diagnose, treat, cure, or prevent any disease. Information provided by BrainFx is not a substitute for face-to-face consultation with your health care professional and should not be construed as individual medical advice.